Karah Herdman Parschauer's Net Worth
$8.64 Million
Who is Karah Herdman Parschauer?
Karah Herdman Parschauer has an estimated net worth of $8.64 Million. This is based on reported shares across multiple companies, which include Evolus, Inc., Arcturus Therapeutics Holdings Inc., Tenaya Therapeutics, Inc., Ultragenyx Pharmaceutical Inc., and Anebulo Pharmaceuticals, Inc..
SEC CIK
Karah Herdman Parschauer's CIK is 0001677455
Past Insider Trading and Trends
2020 was Karah Herdman Parschauer's most active year for acquiring shares with 11 total transactions. Karah Herdman Parschauer's most active month to acquire stocks was the month of February. 2020 was Karah Herdman Parschauer's most active year for disposing of shares, totalling 19 transactions. Karah Herdman Parschauer's most active month to dispose stocks was the month of September. 2020 saw Karah Herdman Parschauer paying a total of $2,603,600.00 for 123,892 shares, this is the most they've acquired in one year. In 2020 Karah Herdman Parschauer cashed out on 108,680 shares for a total of $5,227,546.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Evolus, Inc. (EOLS) Snapshot price: $13.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.69% | 6.46K |
—
|
—
| 37.71K |
Feb 7
| |||
Form 4
| -27.63% | -11.93K |
$13.14 | -$156,732.77 | 31.24K |
Scheduled
|
Jan 30
| ||
Form 4
| +23.78% | 8.29K |
—
|
—
| 43.17K |
Jan 27
| |||
Form 4
| +80.61% | 15.57K |
—
|
—
| 34.88K |
Jan 24
| |||
Form 4
|
∞
| 19.31K |
—
|
—
| 19.31K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcturus Therapeutics Holdings Inc. (ARCT) Snapshot price: $37.86
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tenaya Therapeutics, Inc. (TNYA) Snapshot price: $4.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $44.88
EVP and Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -14.47% | -9.81K |
$45.00 | -$441,270.00 | 57.98K |
Jun 12
| |||
Form 4
| +12.19% | 15K |
$53.76 | -$201,922.56 | 138.08K |
Mar 1
| |||
Form 4
| -7.77% | -4.38K |
$45.00 | -$197,010.00 | 51.98K |
May 4
| |||
Form 4
| +22.94% | 21.5K |
$45.25 | -$143,035.25 | 115.24K |
Mar 1
| |||
Form 4
| -12.99% | -5.14K |
$62.95 | -$323,563.00 | 34.44K |
Mar 7
| |||
Form 4
| +20.61% | 11.11K |
$66.62 | -$192,265.32 | 65.05K |
Mar 1
| |||
Form 4
| -1.08% | -310.00 |
$81.14 | -$25,153.40 | 28.36K |
Oct 14
| |||
Form 4
|
—
|
0
|
$77.58 | -$338,556.40 | 28.67K |
Sep 8
| |||
Form 4
| -4.43% | -1.33K |
$100.00 | -$132,900.00 | 28.67K |
Scheduled
|
Jun 10
| ||
Form 4
| -1.03% | -313.00 |
$113.67 | -$35,578.71 | 30K |
May 6
| |||
Form 4
| +25.63% | 6.17K |
$138.17 | -$548,534.90 | 30.23K |
Mar 1
| |||
Form 4
|
—
|
0
|
$77.31 | -$451,774.86 | 57.93K |
Scheduled
|
Oct 30
| ||
Form 4
|
—
|
0
|
$77.25 | -$4,413.50 | 23.97K |
Scheduled
|
Oct 28
| ||
Form 4
| -1.34% | -325.00 |
$88.00 | -$28,600.00 | 23.97K |
Oct 14
| |||
Form 4
|
—
|
0
|
$74.75 | -$405,000.00 | 24.29K |
Scheduled
|
Oct 8
| ||
Form 4
|
—
|
0
|
$69.22 | -$415,700.00 | 24.29K |
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$66.72 | -$365,700.00 | 24.29K |
Scheduled
|
Sep 23
| ||
Form 4
| -8.89% | -2.37K |
$71.47 | -$548,884.30 | 24.29K |
Aug 17
| |||
Form 4
| -2.38% | -649.00 |
$78.22 | -$50,764.78 | 26.66K |
Jun 20
| |||
Form 4
| -9.06% | -2.72K |
$74.72 | -$203,374.23 | 27.31K |
May 18
| |||
Form 4
| -0.82% | -248.00 |
$66.26 | -$16,432.48 | 29.9K |
May 6
| |||
Form 4
| -0.82% | -248.00 |
$58.57 | -$14,525.36 | 30.15K |
Apr 19
| |||
Form 4
| +59.30% | 11.32K |
$56.08 | -$118,777.44 | 30.4K |
Mar 1
| |||
Form 4
| +8.12% | 1.43K |
—
|
—
| 19.08K |
Oct 14
| |||
Form 4
| -16.01% | -3.36K |
$62.55 | -$210,419.41 | 17.65K |
Scheduled
|
Jun 20 - Jun 24
| ||
Form 4
| +7.32% | 1.43K |
—
|
—
| 21.01K |
May 6
| |||
Form 4
| -2.33% | -468.00 |
$68.30 | -$31,964.40 | 19.58K |
Scheduled
|
Apr 29
| ||
Form 4
| -1.22% | -248.00 |
$64.43 | -$15,978.64 | 20.05K |
Apr 19
| |||
Form 4/A
| +43.11% | 6.11K |
$65.52 | -$58,050.72 | 20.3K |
Mar 1 - Mar 5
| |||
Form 4
| +43.30% | 6.14K |
$67.55 | -$58,093.00 | 20.32K |
Mar 1
| |||
Form 4/A
|
—
|
0
|
$66.52 | -$120,150.00 | 14.18K |
Aug 21
| |||
Form 4
| -35.26% | -5.00K |
$78.53 | -$392,650.00 | 9.18K |
Aug 21
| |||
Form 4
| -7.96% | -1.23K |
$82.77 | -$101,476.02 | 14.18K |
Scheduled
|
Jun 21
| ||
Form 4
| -4.04% | -649.00 |
$85.31 | -$55,366.19 | 15.41K |
Jun 20
| |||
Form 4
| -8.36% | -1.47K |
$60.00 | -$87,900.00 | 16.06K |
Scheduled
|
May 10
| ||
Form 4
| +8.89% | 1.43K |
—
|
—
| 17.52K |
Apr 19
| |||
Form 4
| +82.94% | 7.29K |
$48.43 | -$9,928.15 | 16.09K |
Mar 1
| |||
Form 4
| -7.42% | -705.00 |
$63.38 | -$44,682.90 | 8.79K |
Jun 20
| |||
Form 4
| +26.67% | 2K |
—
|
—
| 9.5K |
Mar 1
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anebulo Pharmaceuticals, Inc. (ANEB) Snapshot price: $2.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||